Menu
GeneBe

rs77316189

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002863.5(PYGL):​c.153C>T​(p.Asp51=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.042 in 1,613,776 control chromosomes in the GnomAD database, including 2,021 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 541 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1480 hom. )

Consequence

PYGL
NM_002863.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.27
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 14-50944251-G-A is Benign according to our data. Variant chr14-50944251-G-A is described in ClinVar as [Benign]. Clinvar id is 193236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-50944251-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PYGLNM_002863.5 linkuse as main transcriptc.153C>T p.Asp51= synonymous_variant 1/20 ENST00000216392.8
PYGLNM_001163940.2 linkuse as main transcriptc.153C>T p.Asp51= synonymous_variant 1/19

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PYGLENST00000216392.8 linkuse as main transcriptc.153C>T p.Asp51= synonymous_variant 1/201 NM_002863.5 P1P06737-1
PYGLENST00000532462.5 linkuse as main transcriptc.153C>T p.Asp51= synonymous_variant 1/201
PYGLENST00000530336.2 linkuse as main transcriptn.220C>T non_coding_transcript_exon_variant 1/51
PYGLENST00000544180.6 linkuse as main transcriptc.153C>T p.Asp51= synonymous_variant 1/192 P06737-2

Frequencies

GnomAD3 genomes
AF:
0.0676
AC:
10292
AN:
152214
Hom.:
537
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0288
Gnomad ASJ
AF:
0.0323
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0318
Gnomad FIN
AF:
0.0549
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0394
Gnomad OTH
AF:
0.0517
GnomAD3 exomes
AF:
0.0426
AC:
10679
AN:
250590
Hom.:
369
AF XY:
0.0418
AC XY:
5669
AN XY:
135716
show subpopulations
Gnomad AFR exome
AF:
0.155
Gnomad AMR exome
AF:
0.0179
Gnomad ASJ exome
AF:
0.0342
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0395
Gnomad FIN exome
AF:
0.0533
Gnomad NFE exome
AF:
0.0408
Gnomad OTH exome
AF:
0.0365
GnomAD4 exome
AF:
0.0393
AC:
57387
AN:
1461444
Hom.:
1480
Cov.:
32
AF XY:
0.0392
AC XY:
28503
AN XY:
727076
show subpopulations
Gnomad4 AFR exome
AF:
0.157
Gnomad4 AMR exome
AF:
0.0198
Gnomad4 ASJ exome
AF:
0.0347
Gnomad4 EAS exome
AF:
0.000202
Gnomad4 SAS exome
AF:
0.0400
Gnomad4 FIN exome
AF:
0.0505
Gnomad4 NFE exome
AF:
0.0373
Gnomad4 OTH exome
AF:
0.0409
GnomAD4 genome
AF:
0.0677
AC:
10312
AN:
152332
Hom.:
541
Cov.:
33
AF XY:
0.0666
AC XY:
4959
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.149
Gnomad4 AMR
AF:
0.0288
Gnomad4 ASJ
AF:
0.0323
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0323
Gnomad4 FIN
AF:
0.0549
Gnomad4 NFE
AF:
0.0394
Gnomad4 OTH
AF:
0.0511
Alfa
AF:
0.0516
Hom.:
149
Bravo
AF:
0.0690
Asia WGS
AF:
0.0240
AC:
83
AN:
3478
EpiCase
AF:
0.0368
EpiControl
AF:
0.0378

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 06, 2015- -
not provided Benign:2
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicApr 12, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 26, 2020- -
Glycogen storage disease, type VI Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
14
DANN
Benign
0.96
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77316189; hg19: chr14-51410969; COSMIC: COSV53584774; API